Valuation: DexCom, Inc.

Market Cap 32.21B 28.62B 26.71B 24.35B 45.92B 3,097B 46.35B 323B 125B 1,583B 121B 118B 5,080B P/E 2026 *
34.3x
P/E 2027 * 28.9x
Enterprise Value 31.45B 27.94B 26.08B 23.77B 44.83B 3,023B 45.25B 316B 122B 1,546B 118B 116B 4,960B EV / Sales 2026 *
6.01x
EV / Sales 2027 * 5.37x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week-0.52%
Current month+0.79%
1 month-2.55%
3 months+21.66%
6 months+40.52%
Current year+33.19%
1 week 75.8
Extreme 75.8
77.2
1 month 71.8
Extreme 71.8
78.8
Current year 48.8
Extreme 48.8
79.6
1 year 47
Extreme 47
79.6
3 years 47
Extreme 47
131.78
5 years 47
Extreme 47
145.65
10 years 47
Extreme 47
145.65
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-0.52% - - 32.54B
+0.84%-3.74%-26.69%+1.85% 167B
-0.07%-2.55%-9.53%+11.07% 111B
+0.90%+1.13%-24.83%+0.58% 105B
-1.24%-1.31%-48.43%-13.54% 74.82B
-0.24%+0.69%+0.16%+72.58% 59.11B
-0.86%+4.49%+17.49%+57.78% 51.8B
-0.71%-3.82%-7.72%-31.41% 48.5B
+0.12%-0.17%-18.21%+20.29% 40.79B
-1.01%-1.45%+28.48%-9.72% 32.54B
Average -0.28%-0.16%-9.92%+12.16% 76.68B
Weighted average by Cap. -0.01%-0.91%-15.96%+9.93%

Financials

2026 *2027 *
Net sales 5.23B 4.65B 4.34B 3.95B 7.46B 503B 7.53B 52.49B 20.34B 257B 19.64B 19.21B 825B 5.8B 5.15B 4.81B 4.38B 8.27B 558B 8.34B 58.2B 22.55B 285B 21.78B 21.3B 915B
Net income 974M 866M 808M 736M 1.39B 93.67B 1.4B 9.78B 3.79B 47.88B 3.66B 3.58B 154B 1.15B 1.02B 953M 868M 1.64B 110B 1.65B 11.53B 4.47B 56.46B 4.31B 4.22B 181B
Net Debt -761M -676M -631M -575M -1.09B -73.17B -1.1B -7.64B -2.96B -37.41B -2.86B -2.8B -120B -1.06B -943M -880M -802M -1.51B -102B -1.53B -10.65B -4.13B -52.17B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
02/10/26 €76.40 -0.52% 78
01/10/26 €76.80 +1.32% 0
30/09/26 €75.80 0.00% 0
29/09/26 €75.80 -0.79% 15
28/09/26 €76.40 -0.26% 25
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
85.36USD
Average target price
95.08USD
Spread / Average Target
+11.39%

Quarterly revenue - Rate of surprise